One of the benefits of a single payer system like Canada or UK is that you are one buying entity that has more bargaining power over drug companies. You can regulate drug prices.

This assumes that the R&D is successful.

What would this look like if their mRNA vaccine failed or more competitors beat them to the punch?

You also have them responding to a Pandemic. Which would make their returns on investment higher.